Metraipolis › archive › dc_acf351df316b

AAV-based gene therapies for neovascular AMD — Europe PMC PMID:41688763

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41688763
DOI
10.1038/s41434-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-05T20:23:17.143Z
SHA-256 of the archived text
4ddc9a94b91844e8b18284f79de5515f8170f68f1e0d06aece782da383040a06
Stable URL of this page
https://metraipolis.com/documento/dc_acf351df316b

How to cite

AAV-based gene therapies for neovascular AMD — Europe PMC PMID:41688763 — Europe PMC (en), https://europepmc.org/article/MED/41688763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_acf351df316b (Metraipolis archive dc_acf351df316b, sha256 4ddc9a94b91844e8b18284f79de5515f8170f68f1e0d06aece782da383040a06)
BibTeX
@misc{dcacf351df316b,
  title = {AAV-based gene therapies for neovascular AMD — Europe PMC PMID:41688763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41688763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_acf351df316b; sha256 4ddc9a94b91844e8b18284f79de5515f8170f68f1e0d06aece782da383040a06},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41688763. Agents can read the archived copy with the MCP tool read_document.